Colchicine Alleviates Non-Atherosclerotic Vascular Aging by Targeting Endothelial Dysfunction and Inflammatory Status
Journal of Inflammation Research · 2026-02 · Volume 19 · 1-15
DOI: 10.2147/jir.s538430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inflammation Research, 2026-02. Verfasst von Soroush Mohammadi Jouabadi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Neth…. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Non-atherosclerotic vascular aging (NAVA) contributes to cardiovascular risk through progressive arterial stiffening and endothelial dysfunction. Colchicine, best known for anti-inflammatory activity, has been proposed to protect vascular structure and function. We evaluated whether chronic colchicine mitigates NAVA in a smooth-muscle-specific ERCC1 knockout (SMC-KO) mouse model of DNA-damage-driven vascular aging.
Methods
We performed experiments in the SMC-KO treated with colchicine (0.1mg/kg/day) or vehicle from the age of 10 to 22 weeks. Endothelial function was assessed by acetylcholine-induced vasorelaxation, and vascular structure by pulse-wave velocity (PWV), carotid intima-media thickness (cIMT), and elastin integrity.
Results
SMC-KO mice developed increased arterial stiffness and impaired acetylcholine-mediated relaxation. Chronic colchicine significantly (p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
- Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
- Division of Experimental Cardiology, Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
- Department of Internal Medicine, Northwest Clinics, Alkmaar, the Netherlands.
- Department of Cardiology, Radboud University Nijmegen Medical Centre, the Netherlands.
- Department of Cardiology, Northwest Clinics, Alkmaar, the Netherlands.
ORCID-Profile: Soroush Mohammadi Jouabadi, Martine de Boer, Yoëlle Goos, Dirk J Duncker
Zitieren
APA
Mohammadi Jouabadi, S., Jüttner, A. A., Golshiri, K., Ataei Ataabadi, E., de Boer, M., De Vries, R., Van Veghel, R., Goos, Y., Boon, Y., Musterd-Bhaggoe, U., Duncker, D. J., MaassenVanDenBrink, A., Danser, A. H. J., Bax, W. A., Cornel, J. H., & Roks, A. J. M. (2026). Colchicine Alleviates Non-Atherosclerotic Vascular Aging by Targeting Endothelial Dysfunction and Inflammatory Status. Journal of Inflammation Research, Volume 19, 1-15. https://doi.org/10.2147/jir.s538430
Vancouver
Mohammadi Jouabadi S, Jüttner AA, Golshiri K, Ataei Ataabadi E, de Boer M, De Vries R, et al. Colchicine Alleviates Non-Atherosclerotic Vascular Aging by Targeting Endothelial Dysfunction and Inflammatory Status. Journal of Inflammation Research. 2026;Volume 19:1-15. doi:10.2147/jir.s538430
BibTeX
@article{MohammadiJouabadi2026,
author = {Mohammadi Jouabadi, Soroush and Jüttner, Annika A and Golshiri, Keivan and Ataei Ataabadi, Ehsan and de Boer, Martine and De Vries, Rene and Van Veghel, Richard and Goos, Yoëlle and Boon, Youri and Musterd-Bhaggoe, Usha and Duncker, Dirk J and MaassenVanDenBrink, Antoinette and Danser, A H Jan and Bax, Willem A and Cornel, Jan H and Roks, Anton J M},
title = {Colchicine Alleviates Non-Atherosclerotic Vascular Aging by Targeting Endothelial Dysfunction and Inflammatory Status},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--15},
doi = {10.2147/jir.s538430}
}
EUVIMED